Supporting the Opioid Crisis Task Force with Superior Drug Testing Solutions

From 1999-2017, almost 400,000 people died from an overdose involving any opioid, including prescription and illicit opioids

Opioid Crisis Task Force

Opioids are natural or synthetic chemicals that interact with nerve cell receptors in the body and brain that reduce the intensity of pain signals. They consist of illegal drugs such as heroin, synthetic opioids such as fentanyl and prescription pain medications such as oxycodone, hydrocodone, codeine and morphine. Since 2000 to 2017, the rate of overdose deaths involving opioid related drugs increased by roughly 200% in the Unites States. Due to this severe development, the American Medical Association (AMA) recognized a necessary need for physicians and other health care professionals to take action and combat the opioid epidemic that currently plagues the nation. As shown in table 1, the AMA encourages physicians and health care professionals to undertake six vital actions that will help reverse the current opioid epidemic. To assist with the opioid crisis task force, MedTest Dx assembled key solutions ranging from automated drug screening to drug confirmation testing by LC/MS. We provide a line of high quality and economical automated toxicology analyzers, along with a comprehensive line of open channel drugs of abuse reagents, which can be placed on any clinical chemistry analyzer. Furthermore, we provide convenient and reliable solutions for laboratories that are implementing or performing in-house LC/MS drug confirmation testing.

Why MedTest Dx?

Proven Expertise:

Over 37 years of experience on a global basis

Comprehensive Portfolio:

High quality products and services for chemistry, Drugs of Abuse, hematology and immunoassay

Essential Quality:

FDA Registered, ISO 13485 Certified and cGMP Compliant

Superior Support:

Nationwide field service, expert technical support and market-driven R&D teams

Deaths per Day from an Opioid Overdose in 2018*

People per Hour Die Due to an Opioid Overdose in 2018*

%

Increase in Overdoes Patients Cost from 58k to 92k from 2009 to 2014*

Table 1: Six key actions developed by the American Medical Association

#.

Action

1.
Register and use state prescription drug monitoring programs
2.
Enhance education and training
3.
Support comprehensive treatment for pain and substance use disorders
4.
Help end stigma
5.
Co-prescribe naloxone to patients at risk of overdose
6.
Encourage safe storage and disposal of opioids and all medications

References:

  1. Centers for Disease Control and Prevention. 2018 Annual Surveillance Report of Drug-Related Risks and Outcomes — United States. Surveillance Special Report 2. S. Department of Health and Human Services. Published August 31, 2018.
  2. Wide-ranging online data for epidemiologic research (WONDER). Atlanta, GA: CDC, National Center for Health Statistics; 2017. Available at http://wonder.cdc.gov.
  3. US opioid epidemic reaches new level of crisis in overdoses, hospitalizations and cost. (2017, August 28).https://www.eurekalert.org/pub_releases/2017-08/aabu-uoe082517.php.
  4. Yvette C. Terrie. “An Overview of Opioids.” Pharmacy Times, June 2011. https://www.pharmacytimes.com/publications/issue/2011/june2011/an-overview-of-opioids
  5. American Medical Association (AMA). “Opioids: Reversing the Opioid Epidemic.” 2019, https://www.ama-assn.org/delivering-care/opioids/reversing-opioid-epidemic.